MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2022 International Congress

    ASYMMETRIC EARLY-ONSET PARKINSONISM DUE TO PSEN1 MUTATION

    E. Luque-Buzo, J. Pérez Sáchez, M. Gonzalez-Sanchez, A. Contreras-Chicote, S. Secades, B. Casa-Fages, F. Grandas (Madrid, Spain)

    Objective: To report a novel case of early-onset parkinsonism due to a presenilin 1 gene (PSEN1) mutation. Background: Mutations in PSEN1 gene are the most…
  • 2022 International Congress

    Non-motor signs in essential tremor and essential tremor-plus syndromes

    A. Nasri, A. Rekik, S. Mrabet, Y. Abida, A. Gharbi, A. Souissi, A. Gargouri, I. Kacem, R. Gouider (Mannouba, Tunisia)

    Objective: To investigate the non-motor profiles of essential tremor (ET) and essential tremor-plus (ET-plus) syndromes. Background: The recently established concept of differentiating ET from ET-plus…
  • 2022 International Congress

    Head injury prior to Parkinson’s disease predicts faster self-reported motor and cognitive decline

    E. Brown, M. San Luciano, S. Goldman, M. Korell, B. Contreras, C. Tanner (San Francisco, USA)

    Objective: To compare rates of self-reported cognitive and motor decline in people with Parkinson’s Disease (PD) with and without a history of head injury (HI).…
  • 2022 International Congress

    The Unmet needs for advanced Parkinson Disease in -Patients’ during the Covid-19 pandemic in Israel

    N. Simantov, A. Socher, T. Gurevich (Tel-Aviv, Israel)

    Objective: To evaluate the socio-demographic profile and clinical needs of advanced Parkinson's disease patients who were admitted to the neurological department at TASMC during the…
  • MDS Virtual Congress 2021

    A Milestone-based approach to monitoring disease progression in Parkinson’s disease

    M. Brumm, A. Siderowf, T. Simuni, C. Caspell-Garcia, L. Chahine, T. Foroud, V. Arnedo, A. Reimer, C. Tanner, K. Poston, D. Weintraub, S. Hutten, K. Kieburtz, K. Marek, C. Coffey (Iowa City, USA)

    Objective: We used Parkinson Progression Marker Initiative (PPMI) data to assess the frequency of clinically meaningful disease milestones and examine baseline predictors of reaching these…
  • MDS Virtual Congress 2021

    Shannon entropy: a novel tool for assessing pentagon drawing in Parkinson’s disease

    L. Brabenec, P. Klobusiakova, J. Mekyska, I. Rektorova (Brno, Czech Republic)

    Objective: We used a digitizing tablet during PCT as a potential tool for assessing early cognitive deficits in PD yet without major cognitive impairment.  We…
  • MDS Virtual Congress 2021

    Cognitive Impairment in Parkinson’s disease Patients: a Descriptive Study

    R. Nindela, A. Kurniawan, Y. Harun, S. Marisdina, I. Irfannuddin (Palembang, Indonesia)

    Objective: This study aims to describe the cognitive profile in Parkinson's disease (PD) patients. Background: Cognitive impairment is a common non-motor symptom of PD. Cohort…
  • MDS Virtual Congress 2021

    Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson’s disease

    E. Cinar, G. Yalcin-Cakmakli, A. Ulusoy, E. Saka, B. Tel, B. Elibol (Zonguldak, Turkey)

    Objective: To examine the possible neurorestorative effects of chronic rapamycin treatment in AAV-mediated alpha-synuclein (a-syn) overexpression model of Parkinson’s disease (PD), designed to induce hippocampal…
  • MDS Virtual Congress 2021

    Evaluation of bedside tests of attention in delirium superimposed on Parkinson’s disease and dementia

    R. Lawson, S. Richardson, D. Kershaw, D. Davis, B. Stephan, L. Robinson, C. Brayne, L. Barnes, D. Burn, A. Yarnall, JP. Taylor, S. Parker, L. Allan (Newcastle Upon Tyne, United Kingdom)

    Objective: To evaluate the ability of simple bedside tests for attention to detect delirium in those with and without underlying neurodegenerative diseases, including Parkinson’s disease…
  • MDS Virtual Congress 2021

    Single-Trajectory Multiple-Target Deep Brain Stimulation to treat Mobility and Cognition in Parkinson’s Disease: a Double-Blind, Randomized, Cross-Over Pilot Study

    S. Sasikumar, M. Cohn, I. Harmsen, A. Loh, S. Kalia, A. Lozano, A. Fasano (Toronto, Canada)

    Objective: To assess the benefit of deep brain stimulation (DBS) to improve cognition in Parkinson’s Disease (PD). Background: Patients with advanced PD suffer from both…
  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley